Summary

This research study aims to learn more about the impact the hormone aldosterone on the heart. Primary aldosteronism is a condition where the body’s adrenal glands make too much of the hormone aldosterone, which can cause high blood pressure and increase the risk of heart and kidney disease. Treatment with medications that block aldosterone can reduce that risk. This study is trying to learn whether treatment with a medication that blocks aldosterone can improve heart function in people who make too much aldosterone.

Study Name: Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study
Status: Not yet recruiting
Conditions: Primary aldosteronism
Interventions: Drug: Eplerenone
Locations: Brigham and Women’s Hospital, Boston, MA, USA
Study link: https://clinicaltrials.gov/ct2/show/NCT05030545

To search for other studies by topic, location, or status, go to our Clinical Studies page.

©2021 Primary Aldosteronism Foundation — All Rights Reserved

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.

©2021 Primary Aldosteronism Foundation

The Primary Aldosteronism Foundation is a registered 501(c)(3) public charity. Donations are tax deductible in the US.